About: Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 06 March 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2003 (uk) im März 2003 veröffentlichter wissenschaftlicher Artikel (de) article scientifique publié en 2003 (fr) artículu científicu espublizáu en marzu de 2003 (ast) scientific article published on 06 March 2003 (en)
publication date	wds:Q73094434-2DD04438-BA17-47BC-A9A4-F568AA6CCBB9
publication date	2003-03-06 00:00:00Z (xsd:dateTime)
author name string	wds:Q73094434-06CCD7E1-49C1-4AE3-94F5-3B15A4946FD3 wds:Q73094434-113BF5C2-79D6-460D-B04E-75C55D097F80 wds:Q73094434-167380D9-3ACD-4CB4-89F6-C74B089A3BF8 wds:Q73094434-37624C04-AC9C-471E-8730-B5563191F6A1 wds:Q73094434-40FC91D2-1256-45F0-AAD4-A94477E8C90A wds:Q73094434-54797E72-9249-452E-9731-F10E39E73D6A wds:Q73094434-59666A14-AF18-4F8A-B4D6-0A60CC75E2A5 wds:Q73094434-676A5ED0-F195-4FB7-AB61-C0857197809B wds:Q73094434-A6032A05-9896-4826-A015-B2B64C66EFF7 wds:Q73094434-D1B264AC-F64B-4025-8876-C6768DF0A111
author name string	Naoya Uchida Hiroaki Honda Hisamaru Hirai Koiti Inokuchi Kazuo Dan Koichi Miyake Takashi Shimada Miyuki Takatori Mitsuharu Inami Hidemasa Takahuji
rdfs:label	Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis (en) Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis (nl)
skos:prefLabel	Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis (en) Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis (nl)
name	Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis (en) Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis (nl)
title	wds:Q73094434-3FA0E6D8-3D70-494B-8C0B-041FA29513C0
title	Myeloproliferative disease in transgenic mice expressing P230 Bcr/Abl: longer disease latency, thrombocytosis, and mild leukocytosis (en)
page(s)	wds:Q73094434-3581B52F-E773-43D4-8C0A-2693959C0C5F
page(s)	320-323
instance of	wds:Q73094434-CCA5B0F4-C3CE-4B61-87B0-E1EEB28A5A43
instance of	scholarly article
PubMed ID	wds:Q73094434-877B8EA7-CA27-4327-B709-861730347FB9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12623846
PubMed ID	12623846
published in	wds:Q73094434-CEF71E76-1C09-489E-85AF-9B6189ADE93E
published in	Blood
issue	wds:Q73094434-CE173A0E-62DE-4602-BA83-01B8131C5EC5
volume	wds:Q73094434-4A815A93-4CCB-44A9-8A50-644340157883
issue	1
volume	102
DOI	wds:Q73094434-86D79B0B-AAA1-4CC1-8FE4-600D2CB08397
DOI	http://dx.doi.org/10.1182/BLOOD-2002-10-3182
DOI	10.1182/BLOOD-2002-10-3182
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73094434
is cites work of	STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease Maintaining low BCR-ABL signaling output to restrict CML progression and enable persistence Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring e19a2 BCR-ABL fusion transcript in typical chronic myeloid leukaemia: a report of two cases Mouse models as tools to understand and study BCR-ABL1 diseases. Overview of the Use of Murine Models in Leukemia and Lymphoma Research. Oral administration of imatinib to P230 BCR/ABL-expressing transgenic mice changes clones with high BCR/ABL complementary DNA expression into those with low expression. Antiangiogenic gene therapy of myeloproliferative disease developed in transgenic mice expressing P230 bcr/abl
is cites work of	wds:Q33680286-1DDA913B-AB8A-4386-A45F-61C03205AE78 wds:Q36169447-A17050B6-901A-43C7-96C2-68067E9CA7D3 wds:Q43573413-6D3A60CB-9962-47FC-88E7-82D907579775 wds:Q53587163-7E75F59A-7EB1-4CCB-A0A8-BA2F92D0C7B5 wds:Q37995194-ABD2F172-8A33-4F44-8D1D-85A77EE3E2A7 wds:Q38185576-A4731688-213B-47C2-B2E7-4A275E7EA467 wds:Q41874399-2336935E-8E6F-40BF-8FC3-FCA2B7E3473E wds:Q38749909-9A3A2F91-8B80-4925-9B10-51EEFDBB607A

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software